A. Kuwabara

Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response.

K. Rezvani, D. Marin, J. Goldman, 2010, Blood.

need for further investigation into the effects of discontinuing imatinib therapy in those patients who wish to conceive.

K. Rezvani, D. Marin, J. Goldman, 2017 .

without having achieved an optimal response myeloid leukemia who interrupt therapy on account of pregnancy Poor outcome after reintroduction of imatinib in patients with chronic

K. Rezvani, D. Marin, J. Goldman, 2013 .

Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response.

K. Rezvani, D. Marin, J. Goldman, 2010, Blood.